North America to dominate the Global ELISA Test Market till 2026
Increasing need for accurate and quick diagnosis is expected to drive the demand for global ELISA test market in the forecast period.
According to TechSci Research report, “Global ELISA Test Market By Method (Direct ELISA, Indirect ELISA, Sandwich ELISA, and Competitive ELISA) By Application (Vaccine Development, Immunology, Diagnostics, Toxicology, Drug Monitoring and Pharmaceutical Industry, Transplantation, Others (Infectious Diseases, Cancer, Protein Quantitation) By Technology (Chemiluminescent, Colorimetric, Fluorescent) By End User (Hospitals, Diagnostic Centers, Research Laboratories, Others) By Company, By Region, Forecast & Opportunities, 2026”, The global ELISA test market is expected to witness steady growth for the upcoming five years. Enzyme-Linked Immunosorbent Assay (ELISA) test performed to identify the presence of antibodies in a biological liquid sample. ELISA test is utilized as diagnostic tool in a plant pathology and in medicine and used as a quality check for many industries. Increase in growth of the drug discovery market and continuous research and development is attributing to high growth of the global ELISA test market. Increasing prevalence of chronic diseases due to surge in old age population is fostering the growth of the market.
The COVID-19 outbreak across the world which has been declared as pandemic by World Health Organization has affected several economies adversely. Leading authorities World-wide imposed lockdown restrictions and released a set of precautionary measures to contain the spread of novel coronavirus. Coronavirus affected patients started suffering from shortness of breath along with coughing and sneezing and required immediate medical attention form the healthcare facilities. Leading authorities increased the capacity of hospitals as a greater number of patients were getting affected daily and getting admitted into the hospital facilities for treatment. ELISA test is used for presence of antibodies against the SARS-CoV-2 which is the scientific name for the coronavirus after the exposure to virus. Manufacturers started producing larger production volume for making the test kits available in healthcare facilities. After the lockdown restrictions were taken off and due to the ongoing pandemic, and increased patient inflow suffering from COVI-19 in the healthcare facilities, ELISA test market is expected to witness growth during this period.
However, absence of cost-efficient diagnostics test and availability of alternate immunoassays test may create hindrance in the growth of the global ELISA test market.
Browse XX Figures spread through XX Pages and an in-depth TOC on “Global ELISA Test Market”.
https://www.techsciresearch.com/report/elisa-test-market/7621.html
Global ELISA test market is segmented into method, application, technology, end user, regional distribution, and company. Based on end user, ELISA test market is further divided into hospitals, diagnostic centres, research laboratories and others. The hospitals segment is expected to account for major market share for the forecast period, 2022-2026. Increase in number of hospitals constructed around the world to accommodate the high patient inflow in healthcare facilities is considered a major driver for the growth of the global ELISA test market. Support and launch of initiatives from leading authorities of several economies to increase the awareness regarding the health and investments to develop healthcare facilities equipped with latest technology and equipment is facilitating the growth of the hospitals segment. Based on method, market is majorly categorized into direct ELISA, indirect ELISA, sandwich ELISA, and competitive ELISA. The indirect ELISA test segment is expected to hold significant share of the ELISA test market for the next five years as it is economical since a smaller number of antibodies are needed in this test. It is more sensitive as one labelled secondary antibody can bind the primary antibody. Indirect ELISA test allows flexibility as different primary antibodies can be used with single labelled secondary antibody.
F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux SA, Enzo Life Sciences, Inc., BioLegend, Inc., ELISA Technologies, Inc., RayBiotech, Inc., Eurofins Scientific Ltd., Abbott Laboratories Ltd., Danaher Corporation Ltd., Sysmex Corporation Inc., PerkinElmer Inc., Agilent Technologies Inc. are the leading players operating in global ELISA test market. Manufacturers are increasingly focusing on research and development process to fuel higher growth in the market. To meet evolving customer demand with respect to better efficiency and durability, several ELISA test manufacturers are coming up with their technologically advanced offerings.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7621
Customers can also request for 10% free customization on this report.
“High-end investments by the major players for technological advancement of the ELISA test infrastructure to produce results with higher efficiency and sensitivity, and with detection limits. Increase in number of automated instruments and equipment is for the automation of laboratory which reduce the time required for ELISA test results and introduction of cost-efficient technologies is expected to boost the growth of the global ELISA test market. Increase in number of research institutes along with growing demand to detect tumor makers, hormones and autoimmune diseases is expected to propel the growth of the global ELISA test market until 2026” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Global ELISA Test Market By Method (Direct ELISA, Indirect ELISA, Sandwich ELISA, and Competitive ELISA) By Application (Vaccine Development, Immunology, Diagnostics, Toxicology, Drug Monitoring and Pharmaceutical Industry, Transplantation, Others (Infectious Diseases, Cancer, Protein Quantitation) By Technology (Chemiluminescent, Colorimetric, Fluorescent) By End User (Hospitals, Diagnostic Centers, Research Laboratories, Others) By Company, By Region, Forecast & Opportunities, 2026” has evaluated the future growth potential of global ELISA test market and provided statistics & information on market size, shares, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the of global ELISA test market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
